摘要
目的通过多维度筛选标准对中医治疗优势病种进行信息采集,总结中医治疗优势病种的证据概况,确定待评价病种。方法根据《中医优势病种遴选和评价技术指导建议》,组织中华中医药学会相关疾病委员会,从疾病分类与代码、既往优势病种覆盖范畴、临床指南/共识/临床路径现状、文献现况分析、疾病的优先性、科技成果情况6个维度对中医治疗优势病种进行总结,并通过专家共识确定进入评价阶段的病种。结果初步推荐出101个病种,涉及23个疾病领域。其中推荐病种数量较多的是儿科分会/项目组,推荐7个病种,最少的为心血管项目组,推荐病种2个,其他项目组推荐病种数量在3~5个。专家共识会对8个病种不予推荐,包括水痘、2型糖尿病、缺铁性贫血、骨关节炎、惊恐障碍、良性前列腺增生、肾结石、慢性乙型肝炎。最终在筛选环节共确定了93个病种,进入到下一步的循证评价。结论基于多维标准信息的采集,较全面及客观地总结了中医治疗优势病种各维度研究现状,为更科学评价中医药治疗优势病种的优势作用、优势定位和证据水平奠定了研究基础;同时也为未来中医药治疗优势病种各维度的研究方向提供了参考。
Objective The purpose of this study is to collect information on priority diseases in the field of traditional Chinese medicine(TCM)by using multidimensional selection criteria,and to summarize the evidence related to these priority diseases,so as to determine which diseases will be assessed.Methods The diseases committee of the TCM association organized and implemented according to the Technical Guidance on the Selection and Evaluation of Priority Diseases in the Field of TCM.The committee identified priority diseases in TCM by using six dimensions:classification and codes of diseases,coverage of previous diseases,clinical guideline/consensus/clinical pathway,current literature analysis,priority of disease,and scientific and technological achievements.The diseases that progress to the evaluation stage were determined through the expert consensus.Results A total of 101 diseases were preliminarily screened and analyzed,covering 23 disease fields.Pediatrics had the most recommended diseases(7)and cardiovascular diseases(2).Recommendations in other disease areas range from 3 to 5.The expert consensus does not recommend the evaluation of eight diseases:chicken pox,type 2 diabetes,iron deficiency anemia,osteoarthritis,panic disorder,benign prostatic hyperplasia,kidney calculi,and chronic hepatitis B.Therefore,93 diseases are identified in the selection stage and will enter the next evidence-based evaluation.Conclusion Based on the collection of multidimensional selection criteria,the study comprehensively and objectively summarizes the research status of priority diseases in the field of TCM.To lay a foundation for scientifically evaluating the effectiveness,staging,and evidence levels of these priority diseases in TCM.In addition,some suggestions are put forward for the future research direction of each dimension in the field of TCM-priority diseases.
作者
杨思红
赵晖
向兴华
景城阳
谈钰濛
柴嘉琪
梁宁
刘昱
刘小雨
史楠楠
廖星
YANG Sihong;ZHAO Hui;XIANG Xinghua;JING Chengyang;TAN Yumeng;CHAI Jiaqi;LIANG Ning;LIU Yu;LIU Xiaoyu;SHI Nannan;LIAO Xing(Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;China Center for Evidence Based Traditional Chinese Medicine,Beijing 100700,China)
出处
《中国中医基础医学杂志》
CAS
CSCD
2024年第3期423-436,共14页
JOURNAL OF BASIC CHINESE MEDICINE
基金
中国中医科学院科技创新工程项目(CI2021A05503,CI2021A00701-3)
中国中医药循证医学中心“业务研究室主任专项”(2020YJSZX-2)
中央级公益性科研院所基本科研业务费优秀青年科技人才培养专项(ZZ13-YQ-075)。
关键词
优势病种
遴选
评价
证据
Priority diseases
Preliminary screening analysis
Evaluation
Evidence
